Op-Ed: FTC Adds Fuel to the Fire for PBMs. Will Congress Deliver Real Reform?
The FTC's reports and legal actions target PBMs for inflating drug costs and restricting access, focusing on insulin and specialty generics.
The FTC's reports and legal actions target PBMs for inflating drug costs and restricting access, focusing on insulin and specialty generics.